Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: CDK11p58inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling

Figure 1

Immunohistochemistry of CDK11 in tissue microarrays. (A) CDK11 immunostaining was determined in breast cancer and scored as (1) (2) low expression, (3) (4) high expression. All immunohistochemical photomicrographs are magnified 400×. (B) Relationship between CDK11 expression and disease free survival (DFS)/overall survival (OS). P values were calculated using the unadjusted log-rank test.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us